Short answer
Intuitive Surgical (ISRG) filed an 8-K current report with the SEC on October 20, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results announced for quarter ended September 30, 2026.
Intuitive Surgical 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results announced for quarter ended September 30, 2026
- Detailed financial results furnished in Exhibit 99.1
- Exhibit not deemed filed under Exchange Act Section 18, limiting associated liability posture
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $3.05B, up 22%, led by instruments and accessories revenue of $1.80B, up 18%
- Procedure growth 15%, with da Vinci up 14% and Ion up 31%, supporting recurring consumables demand
- System placements accelerated to 546 from 427, including 315 da Vinci 5 systems versus 240
- GAAP EPS $1.49 was reduced by $0.99 from the $450M antitrust settlement charge, pending court approval
- Cash and investments fell to $6.80B after $2.94B of share repurchases, while 2026 procedure growth guidance remains 14% to 15%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Intuitive Surgical 8-K filings
Get the next ISRG 8-K as it lands
Follow ISRG for push alerts, or ask the research agent what this filing means.